Regulation and Innovation: Challenges Ahead

This chapter discusses the negative impact of proposed price controls and bureaucratic regulations on drug innovation and entrepreneurial efforts. It highlights the burdens faced by the biotech industry and the complexities introduced by government institutions that hinder research and development.